2m 2m 2m 2m 2m 2m 2m
RELAY THERAPETCS (RLAY)
NASDAQ
$20.02+$0.08 (+0.40%)
Price as of Nov 11, 2026 7:30 PM EST- $4.4BMarket Cap
- 217.01%1-Year Change
- BiotechnologyIndustry
RELAY THERAPETCS (RLAY)
$20.02+$0.08 (+0.40%)
RLAY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $19.94 | ||
Change | -$0.45 (-2.21%) | ||
Open | $20.00 | ||
High | $20.96 | ||
Low | $19.64 | ||
Previous Close | $20.39 | ||
Volume | 2,402,220 | ||
30-Day Average Volume | 2,556,734 | ||
1-Week Change | 14.33% | ||
1-Month Change | 11.52% | ||
1-Year Change | 217.01% | ||
3-Year Change | 160.31% | ||
5-Year Change | -40.90% | ||
Fundamentals | |||
Shares Outstanding | 221.0M | ||
Total Assets | $901.7M | ||
Market Cap | $4.4B | ||
Enterprise Value | $4.3B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$81.7M | ||
Free Cash Flow | -$63.9M | ||
EBIT | -$81.7M | ||
EBITDA | -$81.5M | ||
Net Working Capital | $805.7M | ||
EPS | -$0.37 | ||
Enterprise Value/EBITDA | -53 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -54 | ||
PEG | -6 | ||
Price/Free Cash Flow | -69 | ||
Price/Operating Cash Flow | -69 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue